Advertisement

Topics

Biosimilar Renflexis PBS listing brings potential for health budget savings for Australia

07:14 EDT 1 Aug 2017 | thePharmaLetter

MSD, the non-North America operating name of US pharma giant Merck & Co, has announced the availability…

Original Article: Biosimilar Renflexis PBS listing brings potential for health budget savings for Australia

NEXT ARTICLE

More From BioPortfolio on "Biosimilar Renflexis PBS listing brings potential for health budget savings for Australia"

Quick Search
Advertisement
 

Relevant Topic

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...